Trial intelligence / Profile preview

MET-GDM implementation study

NL-OMON58414Recruiting

Sponsor
Erasmus MC
Start
May 2026
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of metformin in gestational diabetes mellitus (GDM) (2 arms), sponsored by Erasmus MC. Started May 2026; status: recruiting.

02

Drugs

metformin
03

Conditions

gestational diabetes mellitus (GDM)

Beyond the preview

Go deeper on NL-OMON58414.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON58414.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call